ARCHIVES

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

This article is from The Cancer Letter archive.

Vol. 31 No. 39 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Tucson Conference Could Be Lively

February 16, 1979

Zytiga Plus Prednisone Shows Improvement in PFS and OS Over Prednisone Alone

June 29, 2012

Oncology Nurses Urged To Help Set Agenda For Health Care Reform

May 29, 1992

CCIRC Reviews Two Existing, One Prospective Cooperative Group

March 4, 1977

Miami Core Grant Not Renewed, Status Threatened

September 21, 1990

Kyprolis Demonstrates Overall Response Following FDA Accelerated Approval

August 31, 2012